Drug trial finds no benefit in combination therapy for heart failure with reduced ejection fraction
Patients with heart failure with reduced ejection fraction (HFrEF) did not have better health outcomes if they took sacubitril/valsartan combination therapy compared with valsartan alone, according to new data presented at ...
May 17, 2021
0
5